The Emperor's new vertebroplasty?

Kuritzky, Louis
September 2009
Internal Medicine Alert;9/17/2009 Supplement, p135
The article reports on a randomized, double-blind, sham procedure- controlled trial of vertebroplasty (VERT) for painful osteoporotic fracture in 78 patients.


Related Articles

  • UConn Health Center Researchers Looking at Novel Approach to Osteoporosis Prevention and Treatment. Shaskan, Jane // Townsend Letter for Doctors & Patients;May2002, Issue 226, p27 

    Examines the use of sleeping mat with natural energy field for treating or preventing osteoporosis at the University of Connecticut Health Center in Connecticut. Subject of the clinical trials; Enhancement of intercellular activity to prevent osteoporosis; Effect of an alternative approach on...

  • New drugs for osteoporosis. Comparison of the costs and required returns with those of other drugs intended for long-term use. Edwards, M. // PharmacoEconomics;1999, Vol. 15 Issue 3, p269 

    Specific regulatory guidelines dictate that developing a new drug for osteoporosis will be significantly more expensive and take at least 2 years longer in comparison with other long-term therapies developed using the International Committee on Harmonisation (ICH) general guidelines. Assuming...

  • DRUG PIPELINE.  // Arthritis Today;Sep/Oct2005, Vol. 19 Issue 5, p68 

    The article provides an update on drugs in the U.S. as of September 2005. The drug ibandronate for the treatment and prevention of osteoporosis in postmenopausal women is available in 150-milligram dose. A clinical trial showed a 50 percent improvement in patients with psoriasis who took the...

  • Enthusiastic Volunteer Joins Osteoporosis Study. Lefevre, Ruth // Applied Clinical Trials;Jun2000, Vol. 9 Issue 6, p96 

    Interviews an elderly woman who took part in a clinical trial regarding osteoporosis. Absence of osteoporosis in family history; Criteria for being included in the study; Instructions for the subject to take a pill before having breakfast; Description of screening tests; Consent process; Lack...

  • Vertebroplasty was not effective for painful osteoporotic vertebral fractures. Carey, Timothy S.; Sheps, Cecil G. // ACP Journal Club;12/15/2009, Vol. 151 Issue 6, p7 

    The article focuses on a clinical trial which shows that in patients with painful osteoporotic vertebral fractures, vertebroplasty is not effective in reducing pain and improving physical functioning. The study included 78 patients with back pain of 12 months' duration and 1 or 2 recent...

  • Osteoblast Growth Inhibition by Unfractionated Heparin and by Low Molecular Weight Heparins: An in-vitro Investigation. Kock, H. J.; Handschin, A. E. // Clinical & Applied Thrombosis/Hemostasis;Jul2002, Vol. 8 Issue 3, p251 

    Osteoporosis is a rare but potentially severe complication under high-dose, long-term unfractionated heparin therapy. Low-molecular-weight heparins (LMWHs) have gained increased importance in antithrombotic thetapy over the past decade. Whether this heterogeneous group of drugs carries a...

  • NOI Gets FDA Clearance for Trial of Bone Growth Stimulator.  // Biotech Business;Jan2000, Vol. 13 Issue 1, p7 

    Reports that the National Osteoporosis Institute received clearance from the United States Food and Drug Administration to begin a clinical trial with the Bone Growth Simulator of Orthofix International NV for the treatment of osteoporosis.

  • Major Surgical Treatment of Osteoporotic Vertebral Fractures in the Elderly: A Comparison of Anterior Spinal Fusion, Anterior-Posterior Combined Surgery and Posterior Closing Wedge Osteotomy. Shota Takenaka; Yoshihiro Mukai; Noboru Hosono; Takeshi Fuji // Asian Spine Journal;2014, Vol. 8 Issue 3, p322 

    Study Design: A retrospective study. Purpose: To clarify the differences among the three major surgeries for osteoporotic vertebral fractures based on the clinical and radiological results. Overview of Literature: Minimally invasive surgery like balloon kyphoplasty has been used to treat...

  • Inverse correlation of carotid intima-media thickness with raloxifene serum levels in osteoporosis. Lušin, Tina Trdan; Mrhar, Aleš; Marc, Janja; Trontelj, Jurij; Zavratnik, Andrej; Žegura, Branka; Pfeifer, Marija; Ostanek, Barbara // Wiener Klinische Wochenschrift;Jul2014, Vol. 126 Issue 13/14, p403 

    Background: Raloxifene is a selective oestrogen receptor modulator with effects on bone and breast cancer and cardiovascular disease risk. The aim of this study was to examine the influence of raloxifene treatment on surrogate markers of atherosclerosis and the correlation of these markers with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics